Table 3.
Demographic Information for Healthcare Worker Controls Run on the SARS-CoV-2 Neutralizing Antibody Assay
| Control | Age, y/Sex | Days Since Dose 1, 2 | Vaccine |
|---|---|---|---|
| 1 | 29/F | 80, 52 | M |
| 2 | 28/M | 57, 29 | M |
| 3 | 36/M | 62, 41 | P |
| 4 | 54/F | 91, 69 | P |
| 5 | 66/M | 51, 30 | P |
| 6 | 41/F | 79, 48 | M |
| 7 | 35/F | 92, 62 | M |
| 8 | 59/F | 52, 24 | M |
| 9 | 36/M | 109, 88 | P |
| 10 | 32/F | 102, 72 | M |
| 11 | 52/F | 108, 87 | P |
| 12 | 39/F | 116, 94 | P |
| 13 | 66/F | 110, 89 | P |
| 14 | 28/M | 89, 67 | P |
| 15 | 47/F | 103, 82 | P |
| 16 | 32/F | 112, 91 | P |
| 17 | 46/M | 114, 93 | P |
| 18 | 46/F | 127, 96 | P |
| 19 | 41/M | 112, 93 | P |
| 20 | 39/M | 115, 94 | P |
M, Moderna vaccine; P, Pfizer vaccine.